Specific diseases can imbalance a patient’s immune competence and metabolic state. Dr. Revici’s therapy is designed to compensate the immune system and the metabolic alterations using compounds with either an anabolic or catabolic function.
The determination of the patient’s immune and metabolic status is assessed by comprehensive clinical, laboratory and other up to date diagnostic methods.
Lipids with anabolic or catabolic activity play an essential role in Dr. Revici’s unique therapy for their activity on the immune response to diseases.
Recent research done in Japan and China on the core substances used by Dr. Revici in the anti cancer compounds revealed the mechanisms by which they work.
The lipids used in Dr. Revici’s compounds have the effect of inhibiting new blood vessel formation (anti-angiogenesis) – by suppressing the expression of the Vascular Endothelial Growth Factor, and reprogramming normal cell death absent in the cancer cells (induction of apoptosis) by the inhibition of DNA synthesis.
Many of the patients that received these therapies demonstrated a slow and continuous reduction of the primary and metastatic malignant tumors, without experiencing hair loss, extreme fatigue, nausea or weight loss.